Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer
617.2500 -1.30 (-0.21%)
NSE Aug 28, 2025 15:53 PM
Volume: 23,633
 

617.25
-0.21%
Anand Rathi
We expect it is likely to deliver 18%/22%/25% revenue/EBITDA/PAT CAGRs over FY25-27 due to swelling demand, capacity expansion and mounting exports.
Rossari Biotech Ltd. has an average target of 926.25 from 4 brokers.
More from Rossari Biotech Ltd.
Recommended